In the absence of a known organism, antibiotics must be used which will cover the most common causes of sinusitis, and if patients are not responsive to first line antibiotics, resistant organisms ...

A pharmacist explains whether it works and other available options Azithromycin (brand names: Zithromax, Z-Pak, Zmax, and ...

The results of this metaanalysis suggest that the administration of first-line antimicrobial agents ... suggestion by some experts that advanced antibiotics are preferable to the old antibiotics ...

Use of antibiotics for acute sinusitis ... diagnostic criteria for acute sinusitis. "This finding is an enticing first hint that rapid tests with a high negative predictive value and specificity ...

Searching for effective treatment options for 'Sinusitis symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...

bringing it close to levels where it can no longer be recommended for first-line use. Dr Ashley Hammond’s (Bristol Medical School) project will investigate whether the recent emergence in ...

These diseases become harder, and sometimes impossible, to treat. The diminishing number of effective antibiotics also increases the risk of many medical procedures including surgery, chemotherapy, ...

Antibiotics were once considered a first-line treatment for sinusitis. In fact, a 2001 report in the journal American Family Physician estimated that antibiotics were prescribed for up to 98 ...

Where possible, tackling this head pain head on (without medication like antibiotics ... during the first 3 months of pregnancy, although after 12 weeks, some medication such as paracetamol can be ...

So you never want to take an antibiotic just to be safe. Most common illnesses are viral. That means a cold, flu, coughs, most sore throats and sinus infections shouldn't be treated by antibiotics.

Antibiotics ... is often a list-line antibiotic options for serious multidrug-resistant (MDR) infections. InsightRX – which was founded in 2015 and raised $10 million in a first-round financing ...